Skip to content

Clinical trials

Parkinsonian Disorders trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinsonian Disorders Country / region: Germany Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20112
20122
20144
20181
20193
20204
20211
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated3
Unknown status2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Adamas Pharmaceuticals, Inc.4
Novartis Pharmaceuticals3
Theravance Biopharma2
Bial R&D Investments, S.A.1
CENTOGENE GmbH Rostock1
Institute for Neurodegenerative Disorders1
Radboud University Medical Center1
University Hospital Tuebingen1
University Hospital, Bonn1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease20
Parkinsonian Disorders20
Movement Disorders9
Central Nervous System Diseases8
Neurodegenerative Diseases8
Brain Diseases7
Dyskinesias7
Nervous System Diseases7
Basal Ganglia Diseases3
Dizziness2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.